JP2004532795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532795A5 JP2004532795A5 JP2002533851A JP2002533851A JP2004532795A5 JP 2004532795 A5 JP2004532795 A5 JP 2004532795A5 JP 2002533851 A JP2002533851 A JP 2002533851A JP 2002533851 A JP2002533851 A JP 2002533851A JP 2004532795 A5 JP2004532795 A5 JP 2004532795A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23932800P | 2000-10-10 | 2000-10-10 | |
| PCT/US2001/031501 WO2002030408A2 (en) | 2000-10-10 | 2001-10-10 | Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004532795A JP2004532795A (ja) | 2004-10-28 |
| JP2004532795A5 true JP2004532795A5 (ja) | 2005-12-22 |
Family
ID=22901681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002533851A Pending JP2004532795A (ja) | 2000-10-10 | 2001-10-10 | 上皮および内皮バリアの傍細胞性浸透を促進するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7713949B2 (ja) |
| EP (2) | EP1379235B1 (ja) |
| JP (1) | JP2004532795A (ja) |
| AT (2) | ATE348622T1 (ja) |
| AU (1) | AU2002224354A1 (ja) |
| CA (1) | CA2425215C (ja) |
| DE (2) | DE60125420T2 (ja) |
| DK (2) | DK1754480T3 (ja) |
| ES (1) | ES2276847T3 (ja) |
| MX (1) | MXPA03002934A (ja) |
| WO (1) | WO2002030408A2 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1566447A1 (en) * | 2004-02-20 | 2005-08-24 | Aventis Pharma Deutschland GmbH | Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation |
| WO2009091986A1 (en) * | 2008-01-16 | 2009-07-23 | Lankenau Institute For Medical Research | Use of proton pump inhibitors as drug delivery adjuvants |
| RU2576033C2 (ru) | 2009-12-03 | 2016-02-27 | Опко Хелс, Инк. | Составы на основе гиперсулфатированных дисахаридов |
| CN108069929B (zh) * | 2016-11-18 | 2021-06-15 | 中国科学院大连化学物理研究所 | 3-取代香豆素类衍生物及应用和gpr35受体的激动剂 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1511653A (en) * | 1974-04-16 | 1978-05-24 | Wellcome Found | Anthelmintic compositions and use |
| US4199507A (en) | 1977-05-05 | 1980-04-22 | The Upjohn Company | Oxazole [2,3-c]-coumarin |
| US4917826A (en) | 1985-10-18 | 1990-04-17 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US5373095A (en) | 1985-10-18 | 1994-12-13 | The Upjohn Company | Steroid compounds |
| US5001234A (en) | 1987-04-16 | 1991-03-19 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US5306830A (en) | 1989-04-27 | 1994-04-26 | The Upjohn Company | Substituted 3-amino chromans |
| US5144045A (en) | 1990-11-13 | 1992-09-01 | American Cyanamid Company | Phosphocholine derivative inhibitors of phospholipase A2 |
| US5208223A (en) | 1990-11-13 | 1993-05-04 | American Cyanamid Company | Phosphocholine derivative inhibitors of phospholipase A2 |
| US5234933A (en) * | 1991-10-31 | 1993-08-10 | Board Of Governors Of Wayne State University And Vanderbilt University | Cyclic hydroxamic acids |
| WO1993018062A1 (en) | 1992-03-11 | 1993-09-16 | Kyowa Hakko Kogyo Co., Ltd. | Peptide which inhibits phospholipase c |
| DE4210332C1 (ja) * | 1992-03-30 | 1993-07-15 | Gruenenthal Gmbh, 5100 Aachen, De | |
| US5238832A (en) | 1992-06-08 | 1993-08-24 | Board Of Governors Of Wayne State University | Aryl aliphatic acids |
| AU5076293A (en) | 1992-12-04 | 1994-06-16 | F. Hoffmann-La Roche Ag | Hispidospermidin |
| US5360815A (en) | 1993-06-23 | 1994-11-01 | Merck Frosst Canada, Inc. | Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| US5519163A (en) | 1993-10-15 | 1996-05-21 | Merck & Co., Inc. | Inhibitors of phosphoinositide-specific phospholipase C |
| US5942246A (en) | 1996-02-16 | 1999-08-24 | The Liposome Company, Inc. | Etherlipid containing multiple lipid liposomes |
| ES2329529T3 (es) * | 1996-09-11 | 2009-11-26 | Elizabeth Shanahan-Prendergast | Formulaciones terapeuticas que contienen veneno de serpiente y/o de insecto para la profilaxis y la terapia del neoplasma. |
| IL137672A0 (en) | 2000-08-03 | 2001-10-31 | Dpharm Ltd | Derivatives of branched-chain lipophilic molecules and uses thereof |
-
2001
- 2001-10-10 DE DE60125420T patent/DE60125420T2/de not_active Expired - Fee Related
- 2001-10-10 EP EP01986603A patent/EP1379235B1/en not_active Expired - Lifetime
- 2001-10-10 US US09/974,519 patent/US7713949B2/en not_active Expired - Fee Related
- 2001-10-10 MX MXPA03002934A patent/MXPA03002934A/es unknown
- 2001-10-10 CA CA002425215A patent/CA2425215C/en not_active Expired - Fee Related
- 2001-10-10 EP EP06119516A patent/EP1754480B1/en not_active Expired - Lifetime
- 2001-10-10 DE DE60143975T patent/DE60143975D1/de not_active Expired - Lifetime
- 2001-10-10 AT AT01986603T patent/ATE348622T1/de not_active IP Right Cessation
- 2001-10-10 JP JP2002533851A patent/JP2004532795A/ja active Pending
- 2001-10-10 AT AT06119516T patent/ATE496619T1/de not_active IP Right Cessation
- 2001-10-10 AU AU2002224354A patent/AU2002224354A1/en not_active Abandoned
- 2001-10-10 DK DK06119516.0T patent/DK1754480T3/da active
- 2001-10-10 DK DK01986603T patent/DK1379235T3/da active
- 2001-10-10 ES ES01986603T patent/ES2276847T3/es not_active Expired - Lifetime
- 2001-10-10 WO PCT/US2001/031501 patent/WO2002030408A2/en active IP Right Grant